1 study found for:    Raynaud's | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo

Indicates status has not been verified in more than two years